Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/ijgc-2024-005409 | DOI Listing |
Surgery
January 2025
Department of Surgery, Osaka Internationa Cancer Institute, Osaka, Japan.
Surgery
January 2025
Speciality of Sydney, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Electronic address:
Indian Pediatr
January 2025
Department of Pediatrics, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. Correspondence to: Dr Anil Kumar Goel, Department of Pediatrics, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Objectives: To compare the efficacy and safety of intravenous (IV) ketorolac and IV morphine in the management of severe vaso-occlusive crisis (VOC) in children with sickle cell disease (SCD).
Method: An open-label, randomized controlled trial was conducted from January 2021 to July 2022 wherein children with SCD aged 3 to 15 years, presenting with severe VOC (score > 6 on the Wong-Baker Faces Pain scale) were included. Block randomization with minimization was done and participants received either IV ketorolac (intervention) or IV morphine infusion (standard).
Int J Gynaecol Obstet
January 2025
Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!